LumiraDx Limited (LMDXF)
OTCMKTS: LMDXF · Delayed Price · USD
0.0170
+0.0016 (10.39%)
Apr 26, 2024, 3:56 PM EDT - Market closed

LumiraDx Market Cap

LumiraDx has a market cap or net worth of $5.42 million as of April 26, 2024. Its market cap has decreased by -98.06% in one year.

Market Cap
5.42M
Enterprise Value
382.84M
1-Year Change
-98.06%
Ranking
n/a
Category
Stock Price
$0.02

Market Cap Chart

Since January 27, 2021, LumiraDx's market cap has decreased from $127.00M to $5.42M, a decrease of -95.73%. That is a compound annual growth rate of -65.69%.

History

DateMarket Cap% Change
Jan 8, 20245.10M-52.78%
Jan 5, 202410.80M-12.90%
Jan 4, 202412.40M-9.49%
Jan 3, 202413.70M-12.18%
Jan 2, 202415.60M-22.39%
Dec 29, 202320.10M-1.47%
Dec 28, 202320.40M-5.99%
Dec 27, 202321.70M4.83%
Dec 26, 202320.70M-8.41%
Dec 22, 202322.60M-8.13%
Dec 21, 202324.60M-7.17%
Dec 20, 202326.50M-7.67%
Dec 19, 202328.70M-8.31%
Dec 18, 202331.30M-2.80%
Dec 15, 202332.20M-6.40%
Dec 14, 202334.40M-1.99%
Dec 13, 202335.10M-11.14%
Dec 12, 202339.50M27.83%
Dec 11, 202330.90M-1.28%
Dec 8, 202331.30M-2.80%
Dec 7, 202332.20M-8.26%
Dec 6, 202335.10M2.03%
Dec 5, 202334.40M-10.18%
Dec 4, 202338.30M2.68%
Dec 1, 202337.30M-31.93%
View and export this data all the way back to 2021. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly 696.15B
Novo Nordisk 573.09B
UnitedHealth Group 449.26B
Johnson & Johnson 357.92B
Merck & Co. 321.65B
AbbVie 297.12B
AstraZeneca 220.71B
Thermo Fisher 220.40B
Market Cap Rankings